Skip to content

TG Therapeutics TGTX Inventory turnover

Inventory turnover at other companies

Biogen logo
BiogenBIIB
19×-3.6×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.5×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.9×+0.2×
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
2.2×-0.1×
AbbVie logo
AbbVieABBV
3.8×0.0×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.3×+0.3×

Other financials

Income statement

See full
Revenue$204.9M+69.6%
Gross profit$171.4M+62.8%
Operating income$34.8M+304%
Net income$19.8M+291%
EPS (diluted)$0.12+300%

Balance sheet

See full
Cash & equivalents$442.2M+235%
Total debt$753.6M+197%
Total equity$583.1M+146%
Total assets$1.5B+133%

Cash flow

See full
Operating cash flow-$17.9M+37.7%
CapEx$51.0K+104%
Free cash flow-$17.9M+37.6%

Valuation

See full
Market cap$8.15B-14.3%
Enterprise value$8.46B-11.1%
P/E17.6×-225×
P/S11.6×-13.0×

Profitability

See full
Gross margin83.1%-4.4pp
Operating margin21.3%+5.9pp
Net margin66%+55.8pp
FCF margin-6,328.4%+4,773pp

Returns & leverage

See full
Return on equity112.6%+92.9pp
Debt / equity1.3×+0.2×
Current ratio5.8×+1.8×

Where this comes from

Calculated from TG Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's inventory turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TG Therapeutics's inventory turnover?
TG Therapeutics (TGTX) reported inventory turnover of 1.3× in Q1 2026.
How has TG Therapeutics's inventory turnover changed year-over-year?
TG Therapeutics's inventory turnover increased by 212.4% year-over-year, from 0.4× to 1.3×.
What does inventory turnover mean?
Trailing-twelve-month cost of revenue divided by average inventory. Measures how many times inventory is sold and replaced over the year.